Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Hematologic Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02038777
What this trial is testing

PF-04449913 In Japanese Patients With Select Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia
Pfizer 48
Early research (Phase 1)Ended earlyNCT05961839
What this trial is testing

Study of SGR-2921 in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaHigh-Risk and Very High-Risk Myelodysplastic Syndromes
Schrödinger, Inc. 66
Testing effectiveness (Phase 2)Ended earlyNCT02392572
What this trial is testing

ONC201 in Treating Patients With Relapsed or Refractory Acute Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
Recurrent Acute Lymphoblastic LeukemiaRecurrent Acute Myeloid LeukemiaRecurrent Myelodysplastic Syndrome+3 more
M.D. Anderson Cancer Center 58
Early research (Phase 1)Looking for participantsNCT06703892
What this trial is testing

Evaluate the Safety and Clinical Activity of GF- CART01 (CD20/19 CAR T Cell) in Subjects With Relapsed or Refractory B-Cell Hematological Malignancies

Who this might be right for
Diffuse Large B Cell Lymphoma RelapsedDiffuse Large B Cell Lymphoma RefractoryFollicular Lymphoma ( FL)+3 more
GenomeFrontier Therapeutics TW Co., Ltd. 18
Testing effectiveness (Phase 2)Study completedNCT00661544
What this trial is testing

Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma Patients

Who this might be right for
Multiple MyelomaStem Cell Transplantation
M.D. Anderson Cancer Center 48
Testing effectiveness (Phase 2)Ended earlyNCT00052598
What this trial is testing

Therapeutic Allogeneic Lymphocytes and Aldesleukin in Treating Patients With High-Risk or Recurrent Myeloid Leukemia After Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+12 more
Fred Hutchinson Cancer Center 7
Testing effectiveness (Phase 2)Study completedNCT00049504
What this trial is testing

Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+94 more
Fred Hutchinson Cancer Center 53
Large-scale testing (Phase 3)WithdrawnNCT00019409
What this trial is testing

Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)Study completedNCT01823198
What this trial is testing

Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Erythroid LeukemiaAcute Megakaryoblastic Leukemia+12 more
M.D. Anderson Cancer Center 63
Testing effectiveness (Phase 2)UnknownNCT06189833
What this trial is testing

Phase 2 Study Applying MRD Techniques for Participants With Previously Untreated Multiple Myeloma Treated With D-VRd Prior To and After High-dose Therapy Followed by ASCT - TAURUS

Who this might be right for
Multiple Myeloma
Stichting European Myeloma Network 200
Testing effectiveness (Phase 2)Ended earlyNCT03265717
What this trial is testing

DNA Plasmid Encoding a Modified Human Telomerase Reverse Transcriptase (hTERT), Invac-1 in Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
Invectys 26
Testing effectiveness (Phase 2)UnknownNCT03795597
What this trial is testing

Busulfan, Melphalan, Escalating Carfilzomib Conditioning Auto Stem Cell Transplantation for Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Loyola University 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07029776
What this trial is testing

MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)
University of Arkansas 50
Not applicableActive Not RecruitingNCT05428176
What this trial is testing

A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors

Who this might be right for
Acute LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+1 more
City of Hope Medical Center 332
Testing effectiveness (Phase 2)Looking for participantsNCT05735717
What this trial is testing

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Who this might be right for
Hematologic MalignancyAcute LeukemiaRemission+21 more
Masonic Cancer Center, University of Minnesota 70
Early research (Phase 1)Study completedNCT00509691
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

Who this might be right for
Cancer
University of Louisville 20
Testing effectiveness (Phase 2)Ended earlyNCT03301597
What this trial is testing

NLA101 in Adults Receiving High Dose Chemotherapy for AML

Who this might be right for
Leukemia, Myeloid, Acute
Nohla Therapeutics, Inc. 146
Testing effectiveness (Phase 2)Study completedNCT00941720
What this trial is testing

Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Case Comprehensive Cancer Center 71
Testing effectiveness (Phase 2)Study completedNCT01460420
What this trial is testing

Sequential Trial on Reduced Intensity Conditioning (RIC) Allogeneic Transplantation

Who this might be right for
Hematologic MalignanciesMultiple Myeloma
European Myeloma Network B.V. 49
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06987058
What this trial is testing

RVU120 Rollover Study

Who this might be right for
Advanced Solid TumorsAcute Myeloid Leukaemia (AML)High-risk Myelodysplastic Syndrome
Ryvu Therapeutics SA 14
Next Page